Nippon Sanso Matheson, Inc. – FDA Inspection, Feb 10, 2017

Record Details

This FDA Inspection record concerns Nippon Sanso Matheson, Inc., with an inspection on February 10, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Nippon Sanso Matheson, Inc.
Inspection Date: February 10, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Gloria J. Baca (FDA Associated Person)

View Company Profile

ID · 3b6d9caa-20e3-4639-8cfc-7bad604840b4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1002295
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

21 CFR 211.58Buildings not maintained in good state of repair
21 CFR 211.25(b)Supervisor Training/Education/Experience
21 CFR 211.188(a)Accurate reproduction

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nippon Sanso Matheson, Inc.

FDA Inspection

Nippon Sanso Matheson, Inc.February 10, 2017